Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RECTRON Interim / Quarterly Report 2025

Nov 14, 2025

51998_rns_2025-11-14_f798a6e2-2efe-4271-822b-b95e08532b44.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

1

Stock Code:2302

Rectron Ltd. AND SUBSIDIARIES

Consolidated Financial Statements

With Independent Auditors’ Review Report For the Three Months Ended March 31, 2025 and 2024

Address: No. 71, Zhongshan Rd., Tucheng Dist., New Taipei City, Taiwan Telephone: 886-2-28801122

The independent auditors’ review report and the accompanying consolidated financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ review report and consolidated financial statements, the Chinese version shall prevail.

2

Table of contents


Contents
1.Cover Page
2.Table of Contents
3.Independent Auditors’ Review Report
4.Consolidated Balance Sheets
5.Consolidated Statement of Comprehensive Income
6.Consolidated Statement of Changes in Equity
7.Consolidated Statement of Cash Flows
8.Notes to the Consolidated Financial Statements
(1) Company history
(2) Approval date and procedures of the consolidated financial statements
(3) New standards, amendments and interpretations adopted
(4) Summary of significant accounting policies
(5) Significant accounting assumptions and judgments, and major sources of
estimation uncertainty
(6) Explanation of significant accounts
(7) Related-party transactions
(8) Assets pledged as security
(9) Commitments and contingencies
(10) Losses due to major disasters
(11) Subsequent events
(12) Other
(13) Other disclosures
 Information on significant transactions
 Information on investees
 Information on investment in Mainland China
(14) Segment information
Page

1
2
3
4
5
6
7
8
8
8~10
10~11
11
11~30
30~32
32
32
32
32
33
33~35
35
35
36

Independent Auditors’ Review Report

3

To the Board of Directors of RECTRON LTD. Company

Introduction

We have reviewed the accompanying consolidated balance sheets of the RECTRON LTD. Company and its subsidiaries as of March 31, 2025 and 2024, and the related consolidated statements of comprehensive income, changes in equity and cash flows for the three months ended March 31, 2025 and 2024, and notes to the consolidated financial statements, including a summary of significant accounting policies. Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China. Our responsibility is to express a conclusion on the consolidated financial statements based on our reviews.

Scope of Review

Except as explained in the Basis for Qualified Conclusion paragraph, we conducted our reviews in accordance with the Standard on Review Engagements 2410, "Review of Financial Information Performed by the Independent Auditor of the Entity" of the Republic of China. A review of the consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing of the Republic of China and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Basis for Qualified Conclusion

As stated in Note 4(b), the consolidated financial statements included the financial statements of certain non-significant subsidiaries, which were not reviewed by independent auditors. These financial statements reflect total assets amounting to $346,758 thousand and $238,053 thousand, constituting 13% and 10% of consolidated total assets as of March 31, 2025 and 2024, respectively, total liabilities amounting to $15,882 thousand and $8,961 thousand, constituting 2% and 1% of consolidated total liabilities as of March 31, 2025 and 2024, respectively, and total comprehensive income (loss) amounting to $(52,660) thousand and $2,229 thousand, constituting 813% and 8% of consolidated total comprehensive income (loss) for the three months ended March 31, 2025 and 2024, respectively.

Qualified Conclusion

Except for the adjustments, if any, as might have been determined to be necessary had the financial statements of certain consolidated subsidiaries and equity accounted investee companies described in the Basis for Qualified Conclusion paragraph above been reviewed by independent auditors, based on our reviews, nothing has come to our attention that causes us to believe that the accompanying consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of the RECTRON LTD. Company and its subsidiaries as of March 31, 2025 and 2024, and of its consolidated financial performance and its consolidated cash flows for the three months ended March 31, 2025 and 2024 in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China

3-1

Other Matters

We did not review the financial statements of certain consolidated subsidiaries, with total assets of $40,488 thousand and $21,639 thousand, representing 2% and 1% of the related consolidated total assets as of March 31, 2025 and 2024, and net sales of $525 thousand and $707 thousand, representing 0% and 0% of the related consolidated total net sales for the three months ended March 31, 2025 and 2024, respectively. Those financial statements were reviewed by other auditors whose reports have been furnished to us, and our review, insofar as it relates to the amounts included for certain consolidated subsidiaries, are based solely on the reports of the other auditors.

The engagement partners on the reviews resulting in this independent auditors’ review report are Shih-Chin Chih and Hsin-Ting Huang.

KPMG

Taipei, Taiwan (Republic of China) May 14, 2025

Notes to Readers

The accompanying consolidated financial statements are intended only to present the consolidated financial position, financial performance and its cash flows in accordance with the accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to review such consolidated financial statements are those generally accepted and applied in the Republic of China.

The independent auditors’ review report and the accompanying consolidated financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language independent auditors’ review report and consolidated financial statements, the Chinese version shall prevail.

4

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.) Reviewed only, not audited in accordance with Standards on Auditing as of March 31, 2025 and 2024 Rectron LTD. and Subsidiaries

Consolidated Balance Sheets

March 31, 2025, December 31 and March 31, 2024 (Expressed in Thousands of New Taiwan Dollar)

Assets
Current assets:
1100
Cash and cash equivalents (note 6(a))
1110
Current financial assets at fair value through
profit or loss (note 6(b))
1150
Trade notes receivable net (note 6(c) and (n))
1170
Trade receivables net (note 6(c), (n) and 7)
1200
Other receivables
1220
Total current tax assets
130X
Inventories (note 6(d))
1410
Prepayments(note 7)
1479
Other current assets
Non-current assets:
1517 Non-current financial assets at fair value through
other comprehensive income (note 6(b))
1600 Property, plant and equipment (note 6(e), 8 and 9)
1755 Right-of-use assets (note 6(f), and 9)
1760 Investment property (note 6(g) , 7, 8 and 9)
1990 Other non-current assets (note 6(c))
Total assets
March 31, 2025
Amount
%
$ 488,865
18
184,178
7
1,136
-
129,899
5
20,555
1
483
-
138,971
5
9,467
-
5,099
-
978,653
36
56,606
2
636,216
24
15,365
1
954,501
37
2,172
-
1,664,860
64
2,643,513
100
December 31, 2024 December 31, 2024 March 31, 2024
Amount
%
579,185 24
15,452 1
467
-
111,314
5
18,338
1
-
-
132,144
5
9,207
-
2,983
-
869,090
36
59,273
3
455,806 19
15,574
1
962,707 41
3,225
-
1,496,585 64
2,365,675
100
Liabilities and Equity
Current liabilities:
2100
Short-term borrowings (note 6(h))
2130
Current contract liabilities (note 6(n))
2170
Trade payables
2200
Other payables (note 6(l) and 7 )
2230
Current tax liabilities
2280
Current lease liabilities (note 7 )
2300
Other current liabilities (note 9 )
Non-current liabilities
2580
Non-current lease liabilities (note 7 )
2640
Net defined benefit liability, non-current (note 6(j))
2570
Deferred tax liabilities(note 6(k))
2600
Other non-current liabilities (note 7 )
Total liabilities
Equity (notes 6(l)):
3110
Ordinary shares
3200
Capital surplus
3310
Legal reserve
3320
Special reserve
3351
Retained earnings
3400
Other equity
Total equity
Total liabilities and equity


$
Amount
$ 488,865
184,178
1,136
129,899
20,555
483
138,971
9,467
5,099
978,653
56,606
636,216
15,365
954,501
2,172
1,664,860
2,643,513
Amount
%
564,394
21
132,575
5
793
-
140,210
5
4,218
-
439
-
126,046
5
6,849
-
4,201
-
979,725
36
55,867
2
635,790
24
16,060
1
955,984
37
2,357
-
1,666,058
64
2,645,783
100



$

See accompanying notes to financial statements.

5

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

Reviewed only, not audited in accordance with Standards on Auditing Rectron LTD. and Subsidiaries

Consolidated Statement of Comprehensive Income

For the three months ended March 31, 2025 and 2024 (Expressed in Thousands of New Taiwan Dollar, except for Earnings per Common Share)

For the three months ended March 31

4000
Operating revenue(notes 6(n) and 7)
$ 5000
Operating costs (notes 6(d) and 6(j))
Gross profit from operations
Operating expenses (notes 6(c)6(j)6(o) and 12):
6100
Selling expenses
6200
Administrative expenses
6300
Research and development expenses
Total operating expenses
Net operating income
Non-operating income and expenses(notes 6(p) and 7):
7010
Other income
7020
Other gains and losses
7050
Finance costs
7950
Total non-operating income and expenses
Profit before tax
Total tax expense (note 6(k))
Profit
8300
Other comprehensive income (loss):
8310
Components of other comprehensive income that will not be reclassified to profit or loss:
8316
Unrealized gains (losses) from investments in equity instruments measured at fair value
through other comprehensive income
8349
Income tax related to components of other comprehensive income that will not be
reclassified to profit or loss
Components of other comprehensive income that will not be reclassified to profit or loss
8360
Components of other comprehensive income (loss) that will be reclassified to profit or
loss:
Components of other comprehensive income that will be reclassified to profit or loss:
8361
Exchange differences on translation
8367
Unrealized gains (losses) from investments in debt instruments measured at fair value
through other comprehensive income
)8399
Income tax related to components of other comprehensive income that will be reclassified to
profit or loss (note 6(p))
Total components of other comprehensive income that will be reclassified to
profit or loss
8300
Other comprehensive income, net
8500
Comprehensive income
$
Profit, attributable to:
8610
Profit, attributable to owners of parent
$
Comprehensive income attributable to:
8710
Comprehensive income, attributable to owners of parent
$
Earnings per common share (expressed in dollars) (note 6(m))
9750
Basic earnings per share
$
9810
Diluted earnings per share
$
2025
%

193,476
100
118,826
61
75,190
39
15,252
8
29,287
15
1,710
1
46,249
24
28,941
15
4,450
2
(40,897)
(21)
(48)
-
(36,495)
(19)
(7,554)
(4)
-
-
(7,554)
(4)
(162)
-
-
-
(162)
-
790
-
451
-
-
-
1,241
-
1,079
-
(6,475)
(4)
(7,554)
(4)
(6,475)
(4)
(0.05)


2024
%
147,257
100
92,137
63
55,120
37
9,756
7
33,550
23
1,531
1
44,837
31
10,280
6
2,819
2
9,808
7
(84)
-
12,543
9
22,826
15
4,565
3
18,261
12
1,046
1
-
-
1,046
1
10,105
7
(1,338)
(1)
-
-
8,967
6
10,013
7
28,274
19
18,261
12
28,274
19
0.11
0.11
%
100
63
37
7
23
1
31
6
2
7
-
9
15
3
12
1
-
1

7
(1)
-
6
7
19
12

See accompanying notes to financial statements.

6

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

Reviewed only, not audited in accordance with Standards on Auditing Rectron LTD. and Subsidiaries

Consolidated Statement of Changes in Equity

For the three months ended March 31, 2025 and 2024 (Expressed in Thousands of New Taiwan Dollar)

Balance at January 1, 2024
Net income
Other comprehensive income
Total comprehensive income
Appropriation and distribution of retained earnings:
Cash dividends of ordinary share
Balance at March 31, 2024
Balance at January 1, 2025
Net income
Other comprehensive income
Total comprehensive income
Appropriation and distribution of retained earnings:
Cash dividends of ordinary share
Balance at March 31, 2025
Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Attributable to owners ofparent Total Total equity Total equity
Ordinary
share
Capital surplus Retained earnings Total Other equity
Legal reserve Special reserve Exchange differences on
translation of foreign
financial
statements
Unrealized gains (losses)
from financial assets
measured at fair value
through other
comprehensive income
(83,104)
(4,039)

-
-
10,105
(92)

10,105
(92)

-
-

(72,999)
(4,131)

(98,256)
(5,040)

-
-
790
289

790
289

-

-

(97,466)
(4,751)
$1,663,029
-

-

-

-
$ 1,663,029
$ 1,663,029
-

-

-

-
$ 1,663,029




9
-
-
-
-
9
9
-
-
-
-
9




51,988
-
-
-
-
51,988
60,655
-
-
-
-
60,655




60,074
-
-
-
-
60,074
87,143
-
-
-
-
87,143




87,640
18,261
-
18,261
(51,554)
54,347
126,496
(7,554)
-
(7,554)
(96,456)
22,486




(83,104)
-
10,105
10,105
-
(72,999)
(98,256)
-
790
790
-
(97,466)





(87,143)
-
10,013
10,013
-
(77,130)
(103,296)
-
1,079
1,079
-
(102,217)





1,775,597
18,261
10,013
28,274
(51,554)
1,752,317
1,834,036
(7,554)
1,079
(6,475)
(96,456)
1,731,105







$




























See accompanying notes to financial statements.

7

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

Reviewed only, not audited in accordance with Standards on Auditing

Rectron LTD. and Subsidiaries

Consolidated Statement of Cash Flows

For the three months ended March 31, 2025 and 2024 (Expressed in Thousands of New Taiwan Dollars)

Cash flows from (used in) operating activities:
Profit before tax
Adjustments:
Adjustments to reconcile profit (loss):
Depreciation expenses
Amortization expenses
Expected credit losses (gains)
Interest expenses
Interest income
Dividend income
Net losses (gains) on financial assets at fair value through profit or loss
Foreign exchange gain on financial assets
Property, plant and equipment transferred to expenses
Total adjustments to reconcile profit
Changes in operating assets and liabilities:
Changes in operating assets:
Notes receivable
Trade receivables
Other receivables
Inventories
Prepayments
Other current assets
Total changes in operating assets
Changes in operating liabilities:
Current contract liabilities
Trade payables
Other payables
Other current liabilities
Other non-current liabilities
Net defined benefit liability
Total changes in operating liabilities
Total changes in operating assets and liabilities
Total adjustments
Cash inflow generated from operations
Interest received
Dividends received
Interest paid
Income taxes paid
Net cash flows from operating activities
Cash flows from (used in) investing activities:
Acquisition of financial assets at fair value through profit or loss
Proceeds from disposal of financial assets at fair value through profit or loss
Acquisition of property, plant and equipment
Increase in other non-current assets
Increase in other current liabilities
Net cash flows used in investing activities
Cash flows from (used in) financing activities:
Increase in short-term borrowings
Decrease in short-term borrowings
Repayment of lease principal
Net cash flows used in financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of period
Cash and cash equivalents at the end of period
For For the three months ended March 31, the three months ended March 31, the three months ended March 31, the three months ended March 31, the three months ended March 31,
2025 2024









$
(7,554)
12,707
196
(983)
48
(4,426)
(24)
46,593
(533)
-

53,578

(343)
11,294
(14,834)
(12,925)
(2,618)
(898)

(20,324)

122
5,032
(9,852)
1,477
(299)
(28)

(3,548)

(23,872)

29,706
22,152
2,923
24
(48)
(1,441)

23,610

(98,196)
-
(183,155)
(11)
182,521

(98,841)


(819)

(819)

521
(75,529)
564,394

488,865
22,826
12,211
760
(737)
84
(2,755)
(64)
(5,234)
(1,296)
1315
4,284












$
(50)
(20,203)
(130)
3,434
(2,324)
278
(18,995)
(36)
3,484
(6,705)
7,825
-
(378)
4,190
(14,805)
(10,521)

12,305
2,779
64
(105)
(65)
14,978
(9,089)
16,286
(4,672)
(216)
-
2,849
10,000
(15,000)
(551)

(5,551)
5,206
17,482
561,703
579,185

See accompanying notes to financial statements.

8

(English Translation of Consolidated Financial Statements Originally Issued in Chinese.)

REVIEWED ONLY, NOT AUDITED IN ACCORDANCE WITH THE Standards on Auditing AS OF MARCH 31, 2025 AND 2024

Rectron Ltd. and Subsidiaries

Notes to Consolidated Financial Statements

March 31, 2025 and 2024

(Expressed in Thousands of New Taiwan Dollar, except for Earnings per Share Information and Unless Otherwise Specified)

1. Company history

Rectron Ltd. (the “Company”) was established and approved by the Ministry of Economic Affairs on January 23, 1976. The registered address is No. 71, Zhongshan Road, Tucheng District, New Taipei City. The Company was originally named "Rectron Precision Electronics Industry Co., Ltd." and changed its name to "Rectron Ltd." on June 29, 2000, as resolved by the shareholders' meeting and approved by the Ministry of Economic Affairs.

The Company and its subsidiaries (together referred to as the “Group”) main business operations include the manufacture and sale of various rectifiers, other semiconductor components, rental and sale of real estate, trading of wines, and manufacture and sale of medical equipment.

2. Approval date and procedures of the consolidated financial statements

The consolidated financial statements for the three months ended March 31, 2025 and 2024 were authorized for issuance by the board of directors on May 14, 2025.

3. New standards and interpretations not yet adopted

  • (a) The impact of the International Financial Reporting Standards (“IFRSs”) endorsed by the Financial Supervisory Commission, R.O.C. which have already been adopted.

  • The Group has initially adopted the (following) new amendments, which do not have a significant impact on its consolidated financial statements, from January 1, 2025.

  • Amendments to IAS21“Lack of Exchangeability”

  • (b) The impact of IFRS Accounting Standards endorsed by the FSC but not yet effective The Group has initially adopted the (following) new amendments, which do not have a significant impact on its consolidated financial statements, from January 1, 2025.

  • Amendments to IFRS 9 and IFRS 7 “Amendments to the Classification and Measurement of

Financial Instruments” regarding the application guidance requirements for Section 4.1 of IFRS 9

and the related disclosure requirements of IFRS 7.

  • (c) The impact of IFRS issued by IASB but not yet endorsed by the FSC

The following new and amended standards, which may be relevant to the Group, have been issued

by the International Accounting Standards Board (IASB), but have yet to be endorsed by the FSC:

(Continued)

9

9
Standards
or
Interpretations
IFRS 18
“Presentation
and Disclosure
in Financial
Statements”
Content of amendment
Effective date
per IASB
The new standard introduces three categories of income and
expenses, two income statement subtotals and one single
note on management performance measures. The three
amendments, combined with enhanced guidance on how to
disaggregate information, set the stage for better and more
consistent information for users, and will affect all the
entities.

A more structured income statement: under current
standards, companies use different formats to present
their results, making it difficult for investors to
compare financial performance across companies. The
new standard promotes a more structured income
statement, introducing a newly defined ‘operating
profit’ subtotal and a requirement for all income and
expenses to be allocated between three new distinct
categories based on a company’s main business
activities.

Management performance measures (MPMs): the new
standard introduces a definition for management
performance measures, and requires companies to
explain in a single note to the financial statements
why the measure provides useful information, how it
is calculated and reconcile it to an amount determined
under IFRS Accounting Standards.

Greater disaggregation of information: the new
standard includes enhanced guidance on how
companies group information in the financial
statements. This includes guidance on whether
information is included in the primary financial
statements or is further disaggregated in the notes.
January 1, 2027

The Group is evaluating the impact on its consolidated financial position and consolidated financial performance upon the initial adoption of the abovementioned standards or interpretations. The results thereof will be disclosed when the Group completes its evaluation.

The Group does not expect the following other new and amended standards, which have yet to be endorsed by the FSC, to have a significant impact on its consolidated financial statements:

  • Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets Between an Investor and Its Associate or Joint Venture”

  • IFRS 17 “Insurance Contracts” and amendments to IFRS 17 “ Insurance Contracts”

  • IFRS 19 “Subsidiaries without Public Accountability: Disclosures”

  • Amendments to IFRS 9 and IFRS 7 “Amendments to the Classification and Measurement of Financial Instruments” regarding the application guidance requirements for Sections 3.1 and 3.3 of IFRS 9 and the related disclosure requirements of IFRS 7.

  • Annual Improvements to IFRS Accounting Standards—Volume 11

(Continued)

10

  • Amendments to IFRS 9 and IFRS 7 “Contracts Referencing Nature-dependent Electricity”

4. Summary of significant accounting policies

(1) Statement of compliance

These consolidated financial statements have been prepared in accordance with the preparation and guidelines of IAS 34 “Interim Financial Reporting” which are endorsed and issued into effect by FSC, and do not include all of the information required by the Regulations and International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations and SIC Interpretations endorsed and issued into effect by the FSC (hereinafter referred to IFRS endorsed by the FSC) for a complete set of the annual consolidated financial statements.

Except the following accounting policies mentioned below, the significant accounting policies adopted in the consolidated financial statements are the same as those in the consolidated financial statement for the year ended December 31, 2024. For the related information, please refer to note 4 of the consolidated financial statements for the year ended December 31, 2024.

(2) Basis of consolidation

  • (a) List of subsidiaries in the consolidated financial statements:
Name of
Name of
investor
subsidiary
Principal activity
The
Company
Rectron
(China)
Limited
(Rectron
China)
Sales of rectifiers, etc.
Electronic components
The
Company
RECTRON
ELECTRONIC
ENTERPRISE
S,INC (REEI)
Sales of rectifiers, etc.
Electronic components
The
Company
CHU-TING
ENTERPRISE
CO., LTD.
(Chu-Ting)
Wholesale of tobacco and
alcohol products and
manufacturing and sales of
medical equipment.
Rectron
(China)
Limited
Zhejiang
Rectron
Electronic
Co.,LTD.
(Zhejiang
Rectron)
Manufacturing and sales of
rectifiers and other
electronic components.
Shareholding
March 31,
2025
December
31, 2024
March 31,
2024
Description
100%
100%
100%
Subsidiaries with direct
ownership of voting rights
exceeding 50% of the
total shares issued.
100%
100%
100%
Subsidiaries with direct
ownership of voting rights
exceeding 50% of the
total shares issued.(Note)
100%
100%
100%
Subsidiaries with direct
ownership of voting rights
exceeding 50% of the
total shares issued. (Note)

100%
100%
100%
Subsidiaries with indirect
ownership of voting rights
exceeding 50% of the
total shares issued.

Note : It is an insignificant subsidiary that the financial statements have not been reviewed.

  • (b) List of subsidiaries which are not included in the consolidated financial statements: None.

(3) Income taxes

The income tax expenses have been prepared and disclosed in accordance with paragraph B12 of International Financial Reporting Standards 34, Interim Reporting.

Income tax expenses for the period are best estimated by multiplying pre-tax income for the interim reporting period using the effective annual tax rate as forecasted by the management. This should be recognized fully as tax expense for the current period (and allocated to current and deferred taxes based on its proportionate size).

For a change in tax rate that is substantively enacted in an interim period, the effect of the change should immediately be recognized in the interim period in which the change occurs.

(Continued)

11

Temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and their respective tax bases shall be measured based on the tax rates that have been enacted or substantively enacted at the time of the asset or liability is recovered or settled, and be recognized directly in equity or other comprehensive income as tax expense.

(4) Employee benefits

The pension cost in the interim period was calculated and disclosed on a year-to-date basis by using the actuarially determined pension cost rate at the end of the prior fiscal year.

5. Significant accounting assumptions and judgments, and major sources of estimation uncertainty

The preparation of the consolidated financial statements in conformity with the Regulations and IFRSs (in accordance with IAS 34 “Interim Financial Reporting” and endorsed by the FSC) requires management to make judgments, estimates and assumptions that affect the application of the accounting policies and the reported amount of assets, liabilities, income and expenses. Actual results may differ from these estimates.

Except for the following, the preparation of the consolidated interim financial statements, estimates and underlying assumptions are reviewed on an ongoing basis which are in conformity with the consolidated financial statements for the year ended December 31, 2024. For related information, please refer to note 5 of the consolidated financial statements for the year ended December 31, 2024.

6. Explanation of significant accounts

Except for the following disclosures, there were no material differences in the disclosures of significant accounts between the interim consolidated financial statements for the current period and the 2024 consolidated financial statements. Please refer to note 6 to the 2024 annual consolidated financial statements.

(a) Cash and cash equivalents

Cash on hand and petty cash
Cash in banks
Time deposits
Cash and cash equivalents in the consolidated
statement of cash flows
March 31,
2025
December
31, 2024
March 31,
2024
$ 182
259,568
229,115
311

564,083

-

271
553,314
25,600
$ 488,865
564,394
579,185

Please refer to Note 6(q) for the fair value sensitivity analysis and interest rate risk of the financial assets and liabilities.

(Continued)

12

(b) Financial assets

  1. Current financial assets at fair value through profit or loss
March 31, 2025
December 31, 2024
March 31, 2024
Financial assets
designation as measured at fair
value through profit or loss
Shares of stock of overseas
listed companies - LMT
$ -
-
14,617
Shares of stock of overseas
listed companies - TESLA
131,446
68,186
-
Shares of stock of overseas
listed companies - NVDA
52,002
63,619
-
Assets mandatorily measured at
fair value through profit or loss:
Beneficiary certificates
730
770
835
Total
$ 184,178
132,575
15,452
2. Non-current financial assets at fair value through other comprehensive income
March 31, 2025
December 31, 2024
March 31, 2024
Debt investments at fair value
through other comprehensive
income
Corporate bonds – Apple
$ 26,123
25,602
25,846
Corporate bonds – AT&T
9,420
9,151
9,426
Corporate bonds – Pfizer
4,040
3,929
4,157
Corporate bonds – SocGen
-
-
3,252
Equity investments at fair value
through other comprehensive
income
Shares of stock of unlisted
companies
17,023
17,185
16,592
Total
$ 56,060
55,867
59,273
March 31, 2025
December 31, 2024
March 31, 2024
Financial assets
designation as measured at fair
value through profit or loss
Shares of stock of overseas
listed companies - LMT
$ -
-
14,617
Shares of stock of overseas
listed companies - TESLA
131,446
68,186
-
Shares of stock of overseas
listed companies - NVDA
52,002
63,619
-
Assets mandatorily measured at
fair value through profit or loss:
Beneficiary certificates
730
770
835
Total
$ 184,178
132,575
15,452
2. Non-current financial assets at fair value through other comprehensive income
March 31, 2025
December 31, 2024
March 31, 2024
Debt investments at fair value
through other comprehensive
income
Corporate bonds – Apple
$ 26,123
25,602
25,846
Corporate bonds – AT&T
9,420
9,151
9,426
Corporate bonds – Pfizer
4,040
3,929
4,157
Corporate bonds – SocGen
-
-
3,252
Equity investments at fair value
through other comprehensive
income
Shares of stock of unlisted
companies
17,023
17,185
16,592
Total
$ 56,060
55,867
59,273
March 31, 2025
December 31, 2024
March 31, 2024
Financial assets
designation as measured at fair
value through profit or loss
Shares of stock of overseas
listed companies - LMT
$ -
-
14,617
Shares of stock of overseas
listed companies - TESLA
131,446
68,186
-
Shares of stock of overseas
listed companies - NVDA
52,002
63,619
-
Assets mandatorily measured at
fair value through profit or loss:
Beneficiary certificates
730
770
835
Total
$ 184,178
132,575
15,452
2. Non-current financial assets at fair value through other comprehensive income
March 31, 2025
December 31, 2024
March 31, 2024
Debt investments at fair value
through other comprehensive
income
Corporate bonds – Apple
$ 26,123
25,602
25,846
Corporate bonds – AT&T
9,420
9,151
9,426
Corporate bonds – Pfizer
4,040
3,929
4,157
Corporate bonds – SocGen
-
-
3,252
Equity investments at fair value
through other comprehensive
income
Shares of stock of unlisted
companies
17,023
17,185
16,592
Total
$ 56,060
55,867
59,273




59,273

(1) Debt investments at fair value through other comprehensive income

The Company consolidated investments in bonds measured at fair value through other comprehensive income in the financial statements as of March 31, 2025 December 31, 2024 and March 31, 2024. The effective interest rates range respectively from 2.00% to 4.01%, 2.00% to 4.01%, and 2.00% to 4.90%, and the maturity dates range from 2036 to 2045. The Company holds bond investments through the business model of collecting contractual cash

(Continued)

13

flows and selling financial assets, and therefore reports them as financial assets measured at fair value through other comprehensive income.

  • (2) Equity investments at fair value through other comprehensive income

  • The Group designated the investments shown above as equity securities at fair value through other comprehensive income because these equity securities represent those investments that the Group intends to hold for the long term for strategic purposes.

  • (3) For credit risk (including the impairment of debt investments) and market risk; please refer to note 6(q).

  • (4) As of March 31, 2025, December 31, 2024 and March 31, 2024, the Group’s financial assets were not pledged as collateral.

(c) Trade receivables and notes receivable

March 31, 2025
Notes receivable from operating activities$ 1,136
Trade receivables
152,195
Trade receivables–Non-current
48,227
Less: Loss allowance
(70,523)
$
131,035
December 31, 2024
793
163,249
48,227
(71,266)
141,003
March 31, 2024
467
135,914
48,227
(72,827)
111,781

The Group applies the simplified approach to provide for its expected credit losses, i.e. the use of lifetime expected loss provision for all receivables. To measure the expected credit losses, trade receivables have been grouped based on shared credit risk characteristics and the days past due, as well as incorporated forward looking information, including macroeconomic and relevant industry information. The loss allowance provision were determined as follows:

Current
Within 180 days past due.
More than 180 days
past due
March 31, 2025
Gross carrying
amount
$ 114,574
16,654
70,330
$ 201,558
Weighted-average
loss rate
0.05%~1.88%
0.05%~9.13%
0%~100%
Loss allowance
provision
-
219
70,304
70,523
Current
Within 180 days past due.
More than 180 days
past due
December 31, 2024
Gross carrying
amount
$ 112,799
27,234
72,236
$ 212,269
Weighted-average
loss rate
0.05%~1.97%
0.05%~5.39%
0%~100%
Loss allowance
provision
-
-
71,266
71,266

(Continued)

14

Current
Within 180 days past due.
More than 180 days past
due
March 31, 2024 Loss allowance
provision
32
103
72,692
72,827
Gross carrying
amount
$ 94,880
17,022
72,706
Weighted-
average loss rate
0.05%~1.88%
0.05%~9.13%
0%~100%
$ 184,608

The movements in the allowance for trade receivables and notes receivable were as follows:

Balance at January 1
Impairment losses recognized
Impairment losses reversed
Foreign exchange gains/(losses)
Balance at March 31
For the three months ended March 31 the three months ended March 31 the three months ended March 31
2025
71,266
-
(983)
240
70,523
2024
72,605
11
(748)
959
72,827
$
$

As of March 31, 2025, December 31, 2024 and March 31, 2024, the Group’s the aforementioned

trade receivables and notes receivable were not pledged as collateral.

(d) Inventories

Raw materials and consumables
Work in progress
Finished goods
Merchandise
Goods and materials in transit
Subtotal
Less: Allowance for inventory market decline
and obsolescence
March 31,
2025
December 31,
2024
March 31,
2024
25,984
12,848
78,016
33,806
5,054
155,708

(16,737)
511
8,774
27,877
28,507
1,735
142,404
(16,358)

25,638

19,313

72,785

27,474
4,116


149,326
(17,182)
138,971 **126,046 **
132,144

As of March 31, 2025, January 1to 2024 and March 31, 2024, the details of the cost of sales were as follows:

Inventory that has been sold
Write-down of inventories (Reversal of write-downs)
The impact of actual production capacity being lower
than normal capacity.
**For the three months ** **For the three months ** ended March 31,
2024
85,873
759
3,722
90,354
$ 116,504

As of March 31, 2025, December 31, 2024 and March 31, 2024, the Group’s the aforementioned trade receivables and notes receivable were not pledged as collateral.

(Continued)

15

(e) Property, plant and equipment

The cost and accumulated depreciation of the property, plant and equipment of the Group for the three months ended March 31, 2025 and 2024 were as follows:

Cost:
Balance at January 1, 2025
Additions
Reclassification
Reduction
Effect of movement in exchange rates
Balance at March 31, 2025
Balance at January 1, 2024
Additions
Reclassification
(Effect of movement in exchange rates
Balance at March 31, 2024
Accumulated depreciation:
Balance at January 1, 2025
Depreciation
Reduction
Effect of movement in exchange rates
Balance as of March 31, 2025
Balance as of January 1, 2024
Depreciation
Effect of movement in exchange rates
Balance at March 31, 2024
Carrying value:
Balance at January 1, 2025
Balance at March 31, 2025
Balance at January 1, 2024
Balance at March 31, 2024
Land

181,394
-
-
181,394

181,394
-
-
181,394

-
-
-
-

-
-
-
-
181,394
181,394
181,394
181,394
Buildings and
structures
254,947
-
2,926
257,873
248,881
-
3,478
252,359
149,482
2,585
1,898
153,965
135,743
2,529
2,089
140,361
105,465
103,908
113,138
111,998
Machinery and
equipment
698,340
1,720
2,770

7,405
710,235
677,096
1,318

9,178
687,592
576,196
5,979
6,447
588,622
531,955
5,858
7,778
545,591
122,144
121,613
145,141
142,001
Office
equipment
59,827
57
-
(114)
292
60,062
56,394
887
1,806
424
59,511
54,370
739
(114)
279
55,274
50,817
669
372
51,858
5,457
4,788
5,577
7,653
Construction in
progress
221,330
2,133
(2,770

3,820
224,513
13,337
2,467
(3,121)

77
12,760
-
-

-
-
-
-
-
-
221,330
224,513
13,337
12,760
Total
$ $
$ $
$ $
$ $
$
$
$
$
1,415,838
3,910
-
(114)
14,443
1,434,077

1,177,102

4,672
(1,315)
13,157
1,193,616
780,048
9,303
(114)
8,624
797,861
718,515
9,056
10,239
737,810
635,790
636,216
458,587
455,806

As of March 31, 2025, December 31, 2024 and March 31, 2024, the Property, plant and equipment of the Group had been pledged as collateral for long-term borrowings; please refer to note 8.

For the details regarding the subsidiary Zhejiang Rectron housing and construction relocation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd., please refer to Note 9(b).

(Continued)

16

(f) Right-of-use assets

The Group leases many assets including land and buildings, vehicles, and other equipment.

Information about leases for which the Group is a lessee is presented below:

Cost:
Balance at January 1, 2025
Effect of movement in exchange rates
Balance at March 31, 2025
Balance at January 1, 2024
Effect of movement in exchange rates
Balance at March 31, 2024
Accumulated
depreciation
and impairment losses:
Balance at January 1, 2025
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2025
Balance at January 1, 2024
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2024
Carrying amount:
Balance at January 1, 2025
Balance at March 31, 2025
Balance at January 1, 2024
Balance at March 31, 2024
Land
$ 10,276
188
$ 10,464
$ 9,906
224
$ 10,130
$ 1,891
79
35
$ 2,005
$ 1,520
77
35
$ 1,632
$ 8,385
$ 8,459
$ 8,386
$ 8,498
Buildings

13.716
168
13,884
12,826
533
13,359
8,474
598
111
9,183
5,724
561
251
6,536
5,242
4,701
7,102
6,823
Machinery and
equipment

2514

-

2,514

-

-

-

280

210

-

490

-

-

-

-
2,234
2,024
-
-
Machinery and
equipment

2514

-

2,514

-

-

-

280

210

-

490

-

-

-

-
2,234
2,024
-
-
Other
equipment
343
-
343
343
-
343
144
18
-
162
72
18
-
90
199
181
271
253
Total


26,849
356
27,205

23,075
757
23,832






10,789
905
146
11,840






7,316
656
286
8,258







16,060
15,365
15,759
15,574

For the details regarding the subsidiary Zhejiang Rectron right-of-use assets land relocation agreement with Jiashan Economic Development Zone Asset Management Co., Ltd., please refer to Note 9(b).

(Continued)

17

(g) Investment property

Land and

Cost:
Balance at January 1, 2025
Effect of movement in exchange rates
Balance at March 31, 2025
Balance at January 1, 2024
Effect of movement in exchange rates
Balance at March 31, 2024
Accumulated depreciation and
impairment losses:
Balance at January 1, 2025
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2025
Balance at January 1, 2024
Depreciation for the year
Effect of movement in exchange rates
Balance at March 31, 2024
Carrying amount:
Balance at January 1, 2025
Balance at March 31, 2025
Balance at January 1, 2024
Balance at March 31, 2024
improvements
$ 663,510
-
$ 663,510
$ 663,510
-
$ 663,510
$ -
-
-
$ -
$ -
-
-
$ -
$ 663,510

$ 663,510

$ 663,510

$ 663,510
Buildings
377,011
1,590
378,601
373,879
1,891
375,770
84,537
2,499
574
87,610
73,500
2,499
574
76,573
292,474

290,991

300,379

299,197
Total

1,040,521

1,891

1,042,111

1,037,389

1,891

1,039,280

84,537

2,499

574

87,610

73,500

2,499

574

76,573
955,984
954,501
963,889
962,707
  1. Investment properties are self-owned assets held by the Consolidated Companies. The lease term for investment properties ranges from 1 to 6 years, and it is non-cancellable. Due to the need for organic renewal and industrial transformation and upgrading in the Jiashan Economic and Technological Development Industrial Park, where the subsidiary Zhejiang Rectron is located, Zhejiang Rectron agreed to vacate the premises with Jiashan Economic Development Zone Asset Management Co., Ltd. on September 22, 2024. Therefore, the lease contract was terminated at the end of August 2024. Please refer to Note 9(b) for details.

  2. Due to the restriction in the law at that time, private entities were not allowed to acquire agricultural land. Therefore, the Consolidated Companies appointed Mr. Lin Wen-Teng, one of the directors, to register the real estate investment under his personal name. To ensure the preservation of the Consolidated Companies' assets, the property has been pledged back to the Consolidated Companies.

  3. The fair value of investment property was not significantly different from those disclosed in Note 6(g) of the annual consolidated financial statements for the year ended December 31, 2024.

(Continued)

18

  1. As of March 31, 2025, December 31, 2024 and March 31, 2024, the Property, plant and equipment of the Group had been pledged as collateral for long-term borrowings; please refer to note 8.

(h) Short-term borrowings

Secured bank loans
Unused short-term credit lines
Range of interest rates
March 31, 2025 December 31, 2024
March 31, 2024
$ -
-

10,000
$ 420,000
420,000

390,000
- 1.90%~2.01% 1.90%~2.01%

For the collateral for short-term borrowings, please refer to note 8.

(i)Operating Lease

There were no significant changes in operating lease for the three months ended March 31, 2025 and 2024. Please refer to Note 6(i) of the consolidated financial statements for the year ended December 31, 2024 for other related information.

(j)Provisions

1. Defined benefit plans

Management believes that there was no material volatility of the market, no material reimbursement and settlement or no other material onetime events since prior fiscal year. As a result, the pension cost in the accompanying interim period was measured and disclosed according to the actuarial report as of December 31, 2024 and 2022.

The expenses recognized in profit or loss for the Group are as follows:

Operating cost
Administration expenses
Total
For the Three Months Ended March31 For the Three Months Ended March31
2025
$ -
-
$ -
2024
2
5
7

2. Defined contribution plans

The Group’s employee benefits retirement expenses respectively.

Operating cost
Selling expenses
Administration expenses
Research and development expenses
Total
For the Three Months Ended March31 For the Three Months Ended March31
2025
$ 118
66
219
-
$ 403
2024
134
45
195
11
385
  1. The detailed breakdown of retirement benefit expenses recognized by foreign subsidiaries in accordance with relevant local regulations is as follows:
Administration expenses **For the Three Months Ended March31 **
2025
2024
$ 926
1,026

(Continued)

19

(k) Income tax

  1. The components of income tax for the three months ended March 31, 2025 and 2024 were as follows:
Current tax expenses For the three months ended March 31, For the three months ended March 31, For the three months ended March 31,
2025
$ -
2024
4,565
  1. (1) Company’s income tax return for the year 2023 and been examined by the tax authorities.

  2. (2) The domestic subsidiaries of the Company have filed and settled their corporate income tax returns with the tax authorities up to the fiscal year 2023 as approved.

(l)Capital and other equity

Except for the following disclosure, there was no significant change in capital and other equity for the periods from January 1 to March 31, 2025 and 2024. For the related information, please refer to note 6(l) to the consolidated financial statements for the year ended December 31, 2024.

  1. Retained earnings

If the Company has surplus in the annual final accounts, it shall pay taxes and donations in accordance with the law, offset cumulative losses, and then appropriate 10% as statutory surplus reserve. However, when the statutory surplus reserve has reached the Company's paidin capital, no further appropriation is required. The remaining surplus shall be appropriated or reversed as required by laws and regulations, or transferred to the special surplus reserve. If there is still surplus, together with undistributed surplus at the beginning of the period, it will be classified as distributable surplus. The Board of Directors shall propose a surplus distribution plan for approval by the shareholders' meeting, and distribute dividends to the shareholders.

Taking into account financial, operational, and business factors, the Company may distribute dividends to shareholders, which shall not be less than 10% of the distributable surplus for the current fiscal year. However, if the accumulated distributable surplus is less than 3% of the paid-in capital, no distribution shall be made. Dividends may be distributed in the form of cash dividends or stock dividends. Cash dividends shall be given priority in the distribution of earnings, but stock dividends may also be distributed. The proportion of cash dividends shall not be less than 10% of the total dividend amount.

For the distribution of dividends to shareholders in the form of cash, the Board of Directors is authorized to carry out such distribution with the approval of two-thirds or more of the attending directors and a majority of the attending directors, and to report it to the shareholders' meeting.

  • (i) Legal reserve

When a company incurs profit, the shareholders shall decide on the distribution of the statutory earnings reserve either by issuing new shares or by paying cash of up to 25% of the actual share capital.

(ii) Special reserve

The Company chose to apply the exemption under IFRS 1 at its initial adoption of IFRSs. Any unrealized revaluation surplus, accumulated translation adjustment, and increasing amount incurred from adopting the fair value as cost for the assets classified as investment

(Continued)

20

property at the transition date. According to the Financial Supervisory Commission's Order No. 1010012865 issued on April 6, 2012, an equal amount shall be appropriated to the special surplus reserve. When using, disposing of, or reclassifying related assets, a proportionate reversal of the originally appropriated special surplus reserve may be distributed as earnings.

According to the regulations of the Financial Supervisory Commission, when the Company distributes distributable earnings, the difference between the net amount of reductions in other shareholders' equity items recorded in the current year and the balance of the special surplus reserve mentioned above shall be considered. When distributing earnings for the fiscal year 2024, the Company will allocate the current year's income and the undistributed earnings from previous periods to the special surplus reserve. When distributing earnings for the fiscal year 2025, the Company will allocate the current year's after-tax net profit, along with items other than the current year's after-tax net profit, to the undistributed earnings and the special surplus reserve from previous periods. The Company is not allowed to distribute the amounts related to reductions in other shareholders' equity from previous periods, except for the allocation to the special surplus reserve. In the event of reversals in the amounts of reductions in other shareholders' equity in the future, earnings may be distributed based on the reversed portion. As of March 31, 2025, December 31, 2024, and March 31, 2024, the balance of the special surplus reserve is $87,143 thousand, $87,143 thousand, and $60,074 thousand, respectively.

(iii) Earnings distribution

On March 11, 2025, the Board of Directors resolved the cash dividend amount for the 2024 earnings distribution proposal. Other earnings distribution items will be discussed at the Annual General Meeting of Shareholders on May 29, 2025. Additionally, on March 15, 2024, the Board of Directors resolved the cash dividend amount for the 2022 earnings distribution proposal, with other earnings distribution items being approved at the Annual General Meeting of Shareholders on June 26, 2024. The dividends distributed to shareholders are as follows:

Cash dividends distributed to
ordinary shareholders
2024
Amount
per share
Total
amount
$ 0.58
96,456
2024
Amount
per share
Total
amount
$ 0.58
96,456
2023 2023
Amount
per share
$ 0.58
Amount
per share
0.31
Total
amount
96,456 51,554

The dividends payable as of March 31, 2025 and 2024 amounted to $96,456 thousand and $51,554 thousand, respectively, and were recorded under other payables.

(Continued)

21

(iv) OCI accumulated in reserves

Balance at January 1, 2025
Exchange differences on foreign operations
Unrealized gains (losses) from financial
assets measured at fair value through other
comprehensive income
Balance at March 31, 2025
Balance at January 1, 2024
Exchange differences on foreign operations
Unrealized gains (losses) from financial
assets measured at fair value through other
comprehensive income
Balance at March 31, 2024
Exchange
differences on
translation of
foreign financial
statements

$ (98,256)
790

-
$ (97,466)
$ (83,104)
10,105

$ (72,999)
Unrealized gains
(losses) from
financial assets
measured at fair
value through
other
comprehensive
income
Total
(5,040)
(103,296)
790
289
289
(4,751)
(102,217)
(4,039)
(87,143)
10,105
(92)
(92)
(4,131)
(77,130)

(m) Earnings (Loss) per share

For the three months ended March 31, 2025 and 2024, the Company’s earnings per share were calculated as follows:

  1. Basic earnings (Loss) per share

  2. (i) Profit (Loss) attributable to ordinary shareholders of the Company

Profit/(loss) of the Company for the year For the three months ended
March 31
For the three months ended
March 31
2025
$(7,554)
2024
18,261

(ii) Weighted-average number of ordinary shares

Weighted-average number of ordinary shares(thousand shares)
Earnings (Loss) per share
For the three months
ended March 31
For the three months
ended March 31
2025

166,303
$(0.05)
2024
166,303
0.11

2. Diluted earnings (Loss) per share

The diluted earnings per share of the Group for the fiscal year 2025 and the period from January 1, 2024, to March 31, 2024, are calculated based on the net income attributable to the equity holders of the Company and the adjusted weighted average number of ordinary shares outstanding, considering the dilutive effects of all potential ordinary shares. The calculations are as follows:

(Continued)

22

  • (i) Profit (Loss) attributable to ordinary shareholders of the Company
Profit/(loss) attributable to ordinary shareholders of the
Company (basic)
ii) Weighted-average number of ordinary shares
Weighted-average number of ordinary shares
(thousand shares) (basic)
Effect of employee share bonus
Weighted-average number of ordinary shares
(thousand shares) (diluted)
Earnings (Loss) per share
For the three months ended
March 31
For the three months ended
March 31
2025
2024
$ (7,554)
18,261
For the three months ended
March 31
2025
166,303
-
166,303
$ -
2024
166,303
64
166,367
0.11
  • (ii) Weighted-average number of ordinary shares

As of March 31, 2025, there was a loss and no potential ordinary shares; therefore, diluted earnings per share were not presented.

  • (n) Revenue from contracts with customers

  • i. Disaggregation of revenue

For the three months ended March 31, 2025

Electronics
Division
Primary geographical markets
Asia
$ 156,156
America
24,615
Europe
2,285
Others
270
$ 183,326
Major products/services lines
Electronic Components
Sales
$ 183,326
Rental Income
-
Medical Equipment Sales
-
Wine Trading
-
$ 183,326
Property
Management
Division
5,646
-
-
-
5,646
-
5,646
-
-
5,646
Medical
Equipment
Division
2,641
-
-
-
2,641
-
-
2,641
-
2,641
Wine Trading
Department
1,863
-
-
-

Total
166,306
24,615
2,285
270
**1,863 ** 193,476
-
-
-
1,863
**1,863 **
183,326
5,646
2,641

1,863
193,476

(Continued)

23

For the three months ended March 31, 2024

Electronics
Division
Primary geographical markets
Asia
$ 114,563
America
22,117
Europe
1,302
Others
247
$ 138,229
Major products/services lines
Electronic Components
Sales
$ 138,229
Rental Income
-
Medical Equipment Sales
-
Wine Trading
-
$ 138,229
ii. Contract balances
Property
Management
Division
5,436
-
-
-
5,436
-
5,436
-
-
5,436
Medical
Equipment
Division
2,782
-
-
-
2,782
-
-
2,782
-
2,782
Wine Trading
Department
810
-
-
-
810
-
-
-
810
**810 **
Total
123,591

22,117

1,302

247
147,257
138,229

5,436

2,782

810
147,257
Trade receivables and notes
receivable
Less: allowance for
impairment
Contract liabilities
March 31, 2025
$ 153,331
(22,296)
$ 131,035
$ 160
December 31, 2024
164,042
(23,039)
March 31, 2024
136,381
(24,600)
141,003 111,781
38 32

For details on trade receivables and allowance for impairment, please refer to note 6(c).

(o) Remunerations to employees, directors and supervisors

The Company’ s Articles of Incorporation require that earnings shall first be offset against any deficit, then, a minimum of 1% will be distributed as employee remuneration, and a maximum of 2% will be allocated as remuneration to directors. Employees who are entitled to receive the above- mentioned employee remuneration, in share or cash, include the employees of the Company’s subsidiaries who meet certain specific requirements.

For the three months ended March 31, 2025 and 2024, remuneration of employees of $0 thousand and $240 thousand, respectively, and remuneration of directors of $0 thousand and $430 thousand, respectively, were estimated on the basis of the Company’s net profit before tax, excluding the remuneration of employees and directors of each period, multiplied by the percentage of remuneration of employees and directors as specified in the Company’s articles of incorporation. Such amounts were recognized as operating expenses for the three months ended March 31, 2025 and 2024, Management is expecting that the differences, if any, between the actual distributed

(Continued)

24

amounts and estimated amounts will be treated as changes in accounting estimates and will be charged to profit or loss. The number of shares to be distributed was calculated based on the closing price of the Company’s ordinary shares, one day prior to Board of Directors meeting.

The amounts of employee and directors/supervisors compensation for the year 2024 as resolved by the Board of Directors are consistent with the amounts estimated in the 2024 individual financial statements. The amount of employee compensation for the year 2023 as resolved by the Board of Directors is also consistent with the amount estimated in the 2023 individual financial statements. However, the amount of compensation for directors and supervisors as resolved by the Board of Directors differs by $600 thousand from the amount estimated in the 2023 individual financial statements. This difference primarily arises from accounting estimate differences made by the Company and has been recognized in the 2024 income statement. Relevant information can be found on the Market Observation Post System (MOPS).

(p) Non-operating income and expenses

  1. Other income
Interest income
Dividend income
2.
Other gains and losses
Foreign exchange gains
Gains (losses) on financial assets at fair value
through profit or loss
Other
3.
Finance costs
Interest expense
For the three months ended March 31, For the three months ended March 31,
2025
2024
$ 4,426
2,755
24
64
$ 4,450
2,819
For the three months ended March 31,
2024
2,755
64
2,819
2025
2024
$ 5,689
4,531
(46,593)
5,234
7
43
$(40,897)
9,808
For the three months ended March 31,
2024
4,531
5,234
43
9,808
2025
$(48)
2024
(84)

(q) Financial instruments

  1. Credit risk

  2. (i) Credit risk exposure

The carrying amount of financial assets and contract assets represents the maximum amount exposed to credit risk.

  • (ii) Concentration of credit risk

The Group has a broad customer base and does not engage in significant transactions with any single customer. Additionally, its sales are geographically diversified. Therefore, there is no significant concentration of credit risk.

(Continued)

25

(iii) Receivables and debt securities

For credit risk exposure of trade receivables and notes receivable, please refer to note 6(c). Other financial assets at amortized cost include other receivables. All of these financial assets are considered to have low risk, and thus, the impairment provision recognized during the period was limited to 12-month expected credit losses. The fixed deposits held by the group are transacted with and settled by financial institutions that have investmentgrade ratings or above. Therefore, they are considered to have low risk. The loss allowances were determined as follows:

Balance at January 1, 2025
Balance at March 31, 2025
Balance at January 1, 2024
Balance at March 31, 2024
Other receivables
$ 36,992
$ 36,992
$ 36,992
$ 36,992

2. Liquidity risk

The following table shows the contractual maturities of financial liabilities, including estimated interest payments and excluding the impact of netting agreements.

March 31, 2025
Non-derivative financial liabilities
Non-interest bearing liabilities
Lease liabilities(include non-
current)
December 31, 2024
Non-derivative financial liabilities
Non-interest bearing liabilities
Lease liabilities(include non-
current)
March 31, 2024
Non-derivative financial liabilities
Floating rate instruments
Non-interest bearing liabilities
Lease liabilities(include non-
current)
Carrying
amount
Contractual
cash flows
Within 6
months
6-
1 2 months 1-2 years 2 -5 years
Over 5 years
263,264
263,264
263,227
7,141
7,336
1,760
37
1,775
-
3,048
-
-
753
-



$
270,405
270,600
264,987

1812

3,048
753



350,873
350,873
350,836
7,900
8,159
1,729
$
358,773
359,032
352,565

37
1,760
1,797

-
3,334
3,334
-
-
1,336
-

1,336



$ 10,000
10,025
10,025
156,542
156,542
156,542
7,258
7,556
1,243
$
173,800
174,123
167,810

-
-
1,262
1,262

-
-
4,670
4,670

-
-
-
-
381
-
381

The Group does not expect the cash flows included in the maturity analysis to occur significantly earlier or at significantly different amounts.

(Continued)

26

3. Market risk

(i) Currency risk

The Group’s significant exposure to foreign currency risk was as follows:

Financial assets
Monetary items
USD : NTD
USD : CNY
Non-monetary items
USD
Financial liabilities
Monetary items
USD : NTD
USD : CNY
March 31, 2025 December 31, 2024

The Group’s exposure to foreign currency risk arises from the translation of the foreign currency exchange gains and losses on cash and cash equivalents, trade and other receivables, financial assets at fair value through other comprehensive income, and trade and other payables that are denominated in foreign currency.

A strengthening (weakening) of 0.5% of the NTD against the USD, and CNY as at three months of 2025 and 2024 would have increased (decreased) the net profit after tax by $1,156 thousand and $3,345 thousand, and the equity by $158 thousand and $171 thousand. The analysis is performed on the same basis.

Since the Group has many kinds of functional currency, the information on foreign exchange gain (loss) on monetary items is disclosed by total amount. For the three months ended March 31, 2025 and 2024, the foreign exchange gain (loss) (including realized and unrealized portions) amounted to $5,689 thousand and $4,531 thousand, respectively.

  • (ii) Interest rate analysis

Please refer to the notes on liquidity risk management and interest rate exposure of the Group's financial assets and liabilities.

The following sensitivity analysis is based on the exposure to the interest rate risk of derivative and non-derivative financial instruments on the reporting date. Regarding assets with variable interest rates, the analysis is based on the assumption that the amount of assets outstanding at the reporting date was outstanding throughout the year. The rate of change is expressed as the interest rate increases or decreases by 0.5% when reporting to management internally, which also represents the Group management's assessment of the reasonably possible interest rate change.

If the interest rate had increased / decreased by 0.5% basis points, the Group’s net income would have increased / decreased by $0 thousand and $10 thousand for the three months ended March 31, 2025 and 2024, respectively, with all other variable factors remaining constant. This is mainly due to the Group’s borrowing at variable rates.

(Continued)

27

(iii) Other market price risk

For the three months ended March 31, 2025 and 2024, the sensitivity analyses for the changes in the securities price at the reporting date were performed using the same basis for profit or loss as illustrated below:

For the three months ended March 31,
2025
2024
Prices of securities at the
reporting date
Other
comprehensive
income after tax
Net income
Other
comprehensive
income after tax
Net income
For the three months ended March 31, For the three months ended March 31, For the three months ended March 31, For the three months ended March 31, For the three months ended March 31,
2025
2024
Net income
Other
comprehensive
income after tax
Net income
0.5% increase
$
0.5% decrease
$
85

(85)
733
$
(733)
$
83

(83)
58
(58)
  1. Fair value of financial instruments

  2. (i) Fair value hierarchy

The carrying amount and fair value of the Group’s financial assets and liabilities, including the information on fair value hierarchy, were as follows; however, except as described in the following paragraphs, for financial instruments not measured at fair value whose carrying amount is reasonably close to the fair value, and lease liabilities, disclosure of fair value information is not required:

Financial assets at fair value through
profit or loss
Shares of stock of overseas listed
companies
Beneficiary certificates
Subtotal
Financial assets at fair value through
other comprehensive income
Foreign corporate bonds
Stocks in unlisted companies
Subtotal
Financial assets measured at
amortized cost
Cash and cash equivalents
Trade receivables and notes
receivable (including related
parties)
Other receivables
Guarantee deposits paid (Recognition
of other non-current assets)
Subtotal
Total
Financial liabilities measured at
amortized cost
Trade payables
Other payables
Lease liabilities (including non-
March 31, 2025
Fair Value
Level 1
Level 2
Level 3
Total
183,448
-
-
183,448
730
-
-
730
March 31, 2025
Fair Value
Level 1
Level 2
Level 3
Total
183,448
-
-
183,448
730
-
-
730
March 31, 2025
Fair Value
Level 1
Level 2
Level 3
Total
183,448
-
-
183,448
730
-
-
730
Book Value
Level 1 Level 2
-
-
$ 183,448
730
183,448
730
184,178 184,178 - -
184,178
39,583
17,023
-
-
39,583
17,023

-
39,583

-
17,023
56,606 - 56,606
-
56,606
488,865
131,035
20,555
1,415
-
-
-
-
-
-
-
-
-
-
-
-

641,870

$
882,654
184,178 56,606
240,78

$ 136,385
126,879
7,141

-
-
-

-
-
-


-
-
-
-
-
-

(Continued)

28

current)
Guarantee deposits received
(Recognition of other non-current
liabilities)
Total
Financial assets at fair value through
profit or loss
Shares of stock of overseas listed
companies
Beneficiary certificates
Subtotal
Financial assets at fair value through
other comprehensive income
Foreign corporate bonds
Stocks in unlisted companies
Subtotal
Financial assets measured at
amortized cost
Cash and cash equivalents
Trade receivables and notes
receivable (including related
parties)
Other receivables
Guarantee deposits paid (Recognition
of other non-current assets)
Subtotal
Total
Financial liabilities measured at
amortized cost
Trade payables
Other payables
Lease liabilities (including non-
current)
Guarantee deposits received
(Recognition of other non-current
liabilities)
Total
4,354 4,354 -
-
-
-
- -

$
274,759
December 31, 2024 Total
131,805
770
Book Value
$131,805
770
132,575
Fair Value
Level 1
131,805
770
Level 2 Level 3
-
-
-


-

-

-
-
-
-
-
-
-
-
38,682
17,185
132,575
132,575 132,575




38,682
17,185

-
-
-
-
-
-
-

38,682
17,185
55,867
-
-
-
-

55,867

55,867

564,394
141,003
4,218
1,413

-
-
-
-
$
711,028
- - - -
899,470 132,575 55,867 188,442

$131,353
219,520
7,900
4653

-
-
-
-

-
-
-
-

-
-
-
-

-
-
-
-
$
363,426

(Continued)

29

Financial assets at fair value through
profit or loss
Shares of stock of overseas listed
companies
Beneficiary certificates
Subtotal
Financial assets at fair value
through other comprehensive
income
Foreign corporate bonds
Stocks in unlisted companies
Subtotal
Financial assets measured at
amortized cost
Cash and cash equivalents
Trade receivables and notes
receivable (including related
parties)
Other receivables
Guarantee deposits paid (Recognition
of other non-current assets)
Subtotal
Total
Financial liabilities measured at
amortized cost
Bank loans
Trade payables and notes payables
Other payables
Lease liabilities (including non-
current)
Guarantee deposits received
(Recognition of other non-current
liabilities)
Total
March 31, 2024 March 31, 2024 March 31, 2024 Total
14,617
835
Book Value Fair Value
Level 1 Level 2
-
-
Level 3
-
-
$ 14,617
835
14,617
835
15,452 15,452 - - 15,452
42,681
16,592
-
-
42,681
16,592

-

-
42,681
16,592
59,273 - 59,273
-
59,273
579,185
111,781
18,338
319
709,623
-
-
-
-
-
-
-
-
-
-
-
-

$
784,348
15,452 59,273 74,725

$ 10,000
79,181
77,361
7,258
4,756

-
-
-
-

-
-
-
-

-
-
-
-

-
-
-
-

$
178,556

(ii) Valuation techniques for financial instruments measured at fair value

A financial instrument is regarded as being quoted in an active market if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency and those prices represent actual and regularly occurring market transactions on an arm’s-length basis. Whether transactions are taking place ‘regularly’ is a matter of judgment and depends on the facts and circumstances of the market for the instrument.

Quoted market prices may not be indicative of the fair value of an instrument if the activity in the market is infrequent, the market is not well-established, only small volumes are traded, or bid-ask spreads are very wide. Determining whether a market is active involves judgment.

(Continued)

30

Measurements of fair value of financial instruments without an active market are based on valuation technique or quoted price from a competitor. Fair value, measured by using valuation technique that can be extrapolated from either similar financial instruments or discounted cash flow method or other valuation techniques, including models, is calculated based on available market data at the reporting date.

  • (iii) Transfers between Level 1 and Level 2

There were no transfers from level 2 to level 1 for the three months ended March 31, 2025 and 2024.

(r)Financial risk management

There were no significant changes in the Group's financial risk management and policies as disclosed in note 6(r) to the consolidated financial statements for the year ended December 31, 2024.

  • (s) Capital management

Management believes that the objectives, policies and processes of capital management of the Group has been applied consistently with those described in the consolidated financial statements for the year ended December 31, 2024. Also, management believes that there were no significant changes in the Group's capital management information as disclosed for the year ended December 31, 2024. Please refer to note 6(s) to the consolidated financial statements for the year ended December 31, 2024 for further details.

  • (t) Non-cash Investing and Financing Activities

Acquisition of right-of-use assets through leasing. Please refer to Note 6(f) for details.

7. Related-party transactions

  • (a) Names and relationships with related parties

The followings are entities that have had transactions with related party during the periods covered in the consolidated financial statements.

Name of related party Relationship with the Group
Lin, I-Chin

LIN, WEN-TENG

Sunrise On The Bund Hotel
(Sunrise)

PU HWUA ENTERPRISE CO.,
LTD. (Pu Hwua)

Juyang Xingye Industrial Co.,
Ltd. ( Juyang Xingye)

Juiye Enterprise Co., Ltd. (Juiye
Enterprise)
Chairman of this company
Director of this company
The chairman of the subsidiary is the same as the chairman of the
Company.
Other related parties.
The chairman of the Company is also a director of the subsidiary.
The chairman of the company is a director of the company.

(Continued)

31

(b) Significant transactions with related parties

1. Sales

The amounts of significant sales by the Group to related parties were as follows:

Other related parties For the three months ended
March 31,
For the three months ended
March 31,
2025
$ 1,880
2024

814

The sales price of the group to the related party is not significantly different from the general selling price. The average credit period for related parties as of March 31, 2025, and January 1 to March 31, 2024, is approximately 120 days, while for general customers, it ranges from 30 to 90 days.

2. Receivables from related parties

The receivables from related parties were as follows:

Account
Trade receivables
Relationship

Other related parties
March 31,
2025

$ 1,588
December
31, 2024

1,812
March 31,
2024
468

3. Payables to related parties

The payables to related parties were as follows:

Account Relationship March 31, December
March 31,
2025 31, 2024 2024
Other payables Others $ 54 26 24

4. Leases

The Group collected rental income from other related parties and affiliated companies, reporting lease income of $441 thousand and $430 thousand for the year ended December 31, 2025, and for the period from January 1 to March 31, 2024, respectively. As of March 31, 2025, December 31, 2024, and March 31, 2024, related rental deposits amounted to $207 thousand, $207 thousand and $405 thousand.

In November 2024, the Group rented an office building from the Key management person to be used as its headquarter. A five-year lease contract was signed, in which the rental fee is determined based on nearby office rental rates. The total value of the contract was $5,309 thousand. For the three months ended March 31, 2025, the Group recognized the amounts of $24 thousand and $32 thousand respectively as interest expenses. As of March 31, 2025, December 31, 2024, and March 31, 2024 the balance of lease liabilities amounted to $2,849 thousand, $3,029 thousand and $3,809 thousand respectively.

5. Prepayments

6. Others
Account
Prepayments
Relationship

Others
March 31,
2025

$ 4,023
December
31, 2024

3,138
March 31,
2024
1,459

The Group 's operating expenses to other related parties for the March 31, 2025 and 2024 were $2,270thousand and $368 thousand, respectively.

(Continued)

32

(c) Others

In case of registering real estate under the name of other related parties, please refer to Note 6(7) for details.

(d) Key management personnel compensation

Key management personnel compensation comprised:

Key management personnel compensation comprised:
Short-term employee benefits
Post-employment benefits
For the three months
ended March 31,
2025
$ 3,634
53
$3,687
2024
6,504
38
6,542

8. Assets pledged as security

The carrying amounts of assets pledged as security were as follows:

Assets pledged as
security
Property, plant and
equipment
Investment property
Liabilities
secured by
pledge

Long-term
borrowings
Long-term
borrowings
March 31,
2025
$228,738
49,232
**$277,970 **
December
31, 2024

229,510

49,507

279,017
March 31,
2024
231,531
50,330
281,861

9. Significant Commitments and Contingencies

  • (a) Unrecognized contractual commitments

As of March 31, 2025, December 31, 2024, and March 31, 2024, the detailed amounts of the contract prices for equipment and construction projects entered into by the Group with suppliers are as follows::

Signed-contract
Paid-price
March 31,
2025

$ 260,674
$ 40,921
December
31, 2024

259,598
50,971
March 31,
2024
33,391
28,555

(b) In September 2023, the subsidiary Zhejiang Rectron entered into a relocation compensation agreement with the Jiashan Development Zone due to the strategic transformation of the industrial park in which it operates. The agreed compensation amount was $739,403 thousand (RMB 161,653 thousand). In the same year, it received a signing payment of $369,704 thousand (RMB 80,827 thousand), and an additional $182,521 thousand (RMB 39,904 thousand) was received in March 2025. As of March 30, 2025, a total of $552,225 thousand (RMB 120,731 thousand) had been received and was recorded under other current liabilities.

10. Losses due to major disasters: none

11. Subsequent events: none

(Continued)

33

12. Others

(a)A summary of employee benefits, depreciation, and amortization, by function, is as follows:

By function
By item
For the three months ended March 31, For the three months ended March 31, For the three months ended March 31, For the three months ended March 31,
2025 2024
Cost of
sales
Operating
expenses
Total Cost of
sales
Operating
expenses
Total
Employee benefits
Salary
Labor and health insurance
Pension
Others
Depreciation
Amortization
6,762
349
118
131
9,713
81
22,983
2,173
1,211
1,242
2,994
115
29,745
2,522
1,329
1,373
12,707
196
4,873
370
136
171
9,538
120
22,843
1,873
1,282
1,101
2,673
640
27,716
2,243
1,418
1,272
12,211
760

(b)Seasonality of operations

The Group's operations were not affected by seasonality or cyclicality factors.

13. Other disclosure items

(a) Information on significant transaction:

The followings were the information on significant transactions required by the “Regulations Governing the Preparation of Financial Reports by Securities Issuers” for the Group for the three months ended March 31, 2025:

  1. Lending to other parties:

==> picture [426 x 88] intentionally omitted <==

----- Start of picture text -----

Highest
balance Collateral
of Actual Transaction
financing usage Range of Purposes amount for Reasons for Allowance
to other amount interest of fund business short-term for bad Individual Maximum
Number Name of lender borrower Name of Account name Related party parties during the balance Ending during period the during the period rates financing borrower for the two parties between financing debt Item Value loan limits funding financing limit of fund
period
1 Rectron China CHU-TING Other Yes 189,775 152,079 152,079 - 2 - Operation - - - 164,552 164,552
receivables (note 3) (note 4) Requirements
Note 1: For business transactions with counterparties, the business transaction amount is determined based on the cumulative
sales (or purchases) amount between the two parties over the preceding twelve months.
----- End of picture text -----

Note 2: According to our policy, the calculation for the maximum total amount of loans granted are as follows: (1) The Company Individual counterparty funding limit = Shareholders' equity x 40% = $1,731,105thousand x40% = $692,442thousand.

The maximum funding limit for an individual counterparty = Shareholders' equity x 40% = $1,731,105thousand x 40% = $692,442 thousand.

(2) Rectron Electronics (China)

Individual counterparty funding limit = Shareholders' equity x 200% = $82,276thousand x 200% = $164,552 thousand.

The maximum funding limit for an individual counterparty = Shareholders' equity x 200% = $82,276thousand x 200% = $164,552 thousand.

Note 3: Already eliminated during the preparation of the consolidated financial statements.

Note 4: (1) Business transaction with counterparts exists.

  • (2) Short-term funding is necessary.

  • Guarantees and endorsements for other parties: None.

  • Information regarding securities held at the reporting date (subsidiaries, associates and joint ventures not included):

(Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar)
Company holding securities Security type
and name
Relationship
with the
Company
Account March 31, 2025 Remark
Shares Carrying
value
Percentage
of ownership
(%)


Market value
( or net value)
The Company Stock - Sunny Bank - Non-current financial assets
at fair value through other
comprehensive income
1,621,261 17,023 0.05%
17,023
The Company Corporate bonds – Apple - Non-current financial assets
at fair value through other
comprehensive income
-
26,123
-% 26,123

(Continued)

34

34
Company holding securities Security type
and name
Relationship
with the
Company
Account March 31, 2025 Remark
Shares Carrying
value
Percentage
of ownership
(%)

Market value
( or net value)
The Company Corporate bonds – AT&T - Non-current financial assets
at fair value through other
comprehensive income
- 9,420 -% 9,420
The Company Corporate bonds – Pfizer - Non-current financial assets
at fair value through other
comprehensive income
- 4,040 - % 4,040
CHU-TING Fund - Yuanta High Dividend 0056 - Current financial assets at
fair value through profit or
loss
21,000 730 -% 730
CHU-TING Stock - TESLA - Current financial assets at
fair value through profit or
loss
15,850 131,446 -% 131,446
CHU-TING Stock - NVDA - Current financial assets at
fair value through profit or
loss
14,450 52,002 -% 52,002
  1. Information regarding related-party purchases and/or sales exceeding 100 million or 20% of the

Company’s paid-in capital:

(Amounts in Thousands of New Taiwan Dollar)

Company name Related party Nature of relationship Transa ction details Abno
transa
rmal
ction
Trade receivables (payables)
and notes receivable
(payable)
Trade receivables (payables)
and notes receivable
(payable)
Remark
Item Amount Percentage of
the purchases
(sales) (%)
Payment
term
Unit
price
Payment
terms
Ending
balance
Percentage of
total
receivables
(payables)
Rectron China Zhejiang Rectron An investee accounted for
using the equity method by
the Company
Purchase
115,301

41%
Normal Normal 120 days (4) (100)%
Zhejiang
Rectron
Rectron China An investee accounted for
using the equity method by
the Company
Sales (115,301) (31%) Normal Normal 120 days 4 12%

Note: The amount had been offset in the consolidated financial statements.

  1. Information regarding receivables from related parties exceeding 100 million or 20% of the

Company’s paid-in capital:

(Amounts in Thousands of New Taiwan Dollar (Amounts in Thousands of New Taiwan Dollar (Amounts in Thousands of New Taiwan Dollar (Amounts in Thousands of New Taiwan Dollar
Company name Related party Nature of relationship Balance as
September 30,
2024
Turnover
O verdue Amount received in
subsequent period

Allowance
for bad
debts
Amount Action taken
Rectron China The Company Parent-subsidiary relationship 152,079 - % - - - -

Note: The amount had been offset in the consolidated financial statements.

  1. Significant transactions and business relationship between the parent company and its subsidiaries

for the three months ended March 31, 2025:

(Amounts in Thousands of New Taiwan Dollar)

No.
(Note 1)
Company name Counterparty Relationship
(Note 2)

Account
Intercompany transactions Intercompany transactions
Amount Terms Percentage of total
consolidated net sales
or assets
0 Rectron Ltd. Rectron China 1 Operating cost 77,653 Calculated with finished product cost plus
agreedprofit.
40%
0 Rectron Ltd. Rectron China 1 Trade payables 82,221 Adjusted according to the overall funding
situation between the parent and subsidiary
companies, with a term of 120 days as
stipulated in the agreement.
3%
0 Rectron Ltd. REEI 1 Operating revenue 14,435 Calculated with finished product cost plus
agreedprofit.
7%
0 Rectron Ltd. REEI 1 Account receivable
16,055
Adjusted according to the overall funding
situation between the parent and subsidiary
companies, with a term of 120 days as
stipulated in the agreement.
1%
1 Rectron China Zhejiang Rectron 3 Operating cost 115,301 Calculated with finished product cost plus
agreedprofit.
60%
2 CHU-TING Rectron China 3 Other payable 152,079 Adjusted according to the overall funding
situation between the parent and subsidiary
companies, with a term of 120 days as
stipulated in the agreement.
6%

Note 1: Companies are numbered as follows: Parent company 0 Subsidiary starting from 1

(Continued)

35

Note 2: The relationships between transaction parties are numbered as follows: Parent company and subsidiary 1 Subsidiary and parent company 2 Subsidiary and subsidiary 3

(b) Information on investments:

The followings are the information on investees for the three months ended March 31, 2025:

(Amounts in Thousands of New Taiwan Dollar)

Name of
investor
Name of
investee
Location Main businesses Original i
am
nvestment
ount
Balance as of March 31, 2025 as of March 31, 2025 Net income
(loss) of the
investee
Investment
income (loss)
recognised by
the Company
Remark
March 31,
2025
December 31,
2024

Shares
Percentage
Carrying
value
The Company REEI USA Sales of rectifiers, etc. Electronic
components
142,264 142,264 205,000 100.00% 3,997 (1,898) (1,898)
The Company Rectron China Hong
Kong
Sales of rectifiers, etc. Electronic
components
282,573 282,573 20,000 100.00% 82,276 1,809 1,809
The Company CHU-TING Taiwan Wholesale of tobacco and alcohol
products and manufacturing and sales
of medical equipment.

164,987
109,987 20,000,000 100.00% 158,370 (50,762) (50,762)

(c) Information on investment in Mainland China:

  1. Information on the name, principal business activities, and other relevant details of the investee company in Mainland China:
(Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar)
Investee Main businesses
and products
Total amount
of paid-in
capital
Method of
investment
Accumulated
outflow of
investment
from Taiwan as
of January 1,
2025
Inves tment Accumulated
outflow of
investment
from Taiwan as
of March 31,
2025

Net income
(losses) of the
investee
Percentage of
ownership
Investment
income (loss)
recognized
Carrying value
as of March 31,
2025
Accumulated
inward remittance
of earnings as of
March 31, 2025

Outflow
Inflow
Zhejiang Rectron Manufacturing and sales of
rectifiers and other electronic
components.
64,940
USD2,000
(NOTE 1)
(3) 409,029
USD12,000
- 340,857
USD10,000
68,172
USD2,000
3,472 100.00% 3,472 (7,127) -

Note 1: Zhejiang Rectron completed the capital reduction registration on November 15, 2024, reducing capital by USD 10,000 thousand. The original investment amount was offset using the exchange rate of 32.47 on the same date. The funds were remitted back to the Company on January 2, 2025 at an exchange rate of 32.865. Subsequent filing and approval from the Investment Commission of the Ministry of Economic Affairs is pending.

  1. Upper limit on investment in Mainland China:
(Amounts in Thousands of New Taiwan Dollar) (Amounts in Thousands of New Taiwan Dollar)
Accumulated investment in Mainland China
as of March 31, 2025
Investment amount authorized by
Investment Commission, MOEA
Upper limit on investment
66,410
USD 2,000
530,284
USD 15,970
1,038,663

Note 1: Investment methods are categorized into the following three types, simply indicated by their types:

  • (1)Direct investment in mainland China.

(2)Investment in Mainland China through a third-party company in another region (please specify the investment company in that third region).

  • (3)Others method.

Note 2: In the investment gains/losses recognized in this period column:

(1)If it is under preparation and there are no investment gains/losses yet, it should be noted.

(2)The basis for recognizing investment gains/losses is the financial statements audited and certified by the certified public accountant of the Taiwan parent company.

Note 3: According to the "Principles for Reviewing Investment or Technical Cooperation in Mainland China," there are limits to the amount of investment.

Equity net worth × 60% = $1,731,105thousand × 60% = $1,038,663 thousand.

Note 4: Zhejiang Rectron completed the capital reduction registration on November 15, 2024, reducing capital by USD 10,000 thousand, and remitted the funds back to the Company on January 2, 2025. Subsequent filing and approval from the Investment Commission of the Ministry of Economic Affairs is pending.

3. Significant transactions:

The significant inter-company transactions with the subsidiary in Mainland China, which were eliminated in the preparation of consolidated financial statements, are disclosed in “Information on significant transactions”.

(Continued)

36

14. Segment information

(a) General information

The consolidated company has four reporting segments: Electronics, Real Estate Investment, Medical Equipment, and Wine Trading. The Diode segment is engaged in the manufacturing and sales of various rectifiers and other semiconductor components. The Real Estate Investment segment is engaged in the business of leasing office buildings and factories. The Medical Equipment segment is engaged in the business of buying and selling and manufacturing masks. The Wine Trading segment is engaged in the business of trading red and white wines. The reporting segments of the consolidated company are strategic business units that provide different products and services. As each strategic business unit requires different technology and marketing strategies, they need to be managed separately.

  • (b) Information of profit or loss, assets, liabilities, basis and adjustments of which of departments to be reported.

The consolidated company uses the departmental pre-tax profit (excluding non-recurring gains and losses and exchange gains and losses) reviewed by the chief operating decision-maker in the internal management report as the basis for resource allocation and performance evaluation by the management. Since income tax, non-recurring gains and losses, and exchange gains and losses are managed on a group basis, the consolidated company does not allocate income tax expenses (benefits), non-recurring gains and losses, and exchange gains and losses to the reporting segments. In addition, not all significant non-cash items, other than depreciation and amortization, are included in the income statement of all reporting segments. The amounts reported are consistent with the reports used by the operating decision-makers.

The information and adjustments for the operating segments of the consolidated company are as follows:

The Group’s operating segment information and reconciliation are as follows:

For the three
months ended
March 31, 2025
Revenue
Revenue from
external
customers
Intersegment
revenues
Total
revenue
Reportable
segment profit
or loss
For the three
months ended
March 31, 2024
Revenue
Revenue from
external
customers
Intersegment
revenues
Total
revenue
Reportable
segment profit
or loss
Electronics
Department
$ 183,326
207,834
391,160
$39,469
Electronics
Department
$ 138,299
121,848
$260,077
$17,775
Property
Management
Division
5,646
-
5,646
3,664
Property
Management
Division
5,436
-
5,436
3,424
Medical
Devices
Division
2,641
46
2,687
(30,593)
Medical
Devices
Division
2,782
172
2,954
1,037
Wine
Trading
Department
1,863
-
1,863
(20,094)
Wine
Trading
Department
810
-
810
590
Reconciliation
and
elimination
-
(207,880)
(207,880)
-
Reconciliation
and
elimination
-
(122,020)
(122,020)
-
Total
193,476
-
193,476
(7,554)
Total
147,257
-
147,257
22,826

(Continued)